These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 16382046

  • 21. Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents.
    Affar el B, Luke MP, Gay F, Calvo D, Sui G, Weiss RS, Li E, Shi Y.
    Cancer Res; 2006 Apr 01; 66(7):3456-62. PubMed ID: 16585168
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 26. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
    Ma X, Zheng W, Wei D, Ma Y, Wang T, Wang J, Liu Q, Yang S.
    J Biotechnol; 2006 May 29; 123(3):367-78. PubMed ID: 16406157
    [Abstract] [Full Text] [Related]

  • 27. Livin/ML-IAP as a new target for cancer treatment.
    Liu B, Han M, Wen JK, Wang L.
    Cancer Lett; 2007 Jun 08; 250(2):168-76. PubMed ID: 17218055
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and prospects].
    Wu Z, Wang G, Zhang K.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan 08; 34(1):128-32. PubMed ID: 24463134
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
    Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H.
    Oncogene; 2007 Jul 05; 26(31):4550-62. PubMed ID: 17297470
    [Abstract] [Full Text] [Related]

  • 33. Ethyl acetate extract of Chinese medicinal herb Sarcandra glabra induces growth inhibition on human leukemic HL-60 cells, associated with cell cycle arrest and up-regulation of pro-apoptotic Bax/Bcl-2 ratio.
    Li WY, Chiu LC, Lam WS, Wong WY, Chan YT, Ho YP, Wong EY, Wong YS, Ooi VE.
    Oncol Rep; 2007 Feb 05; 17(2):425-31. PubMed ID: 17203183
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
    Blum R, Elkon R, Yaari S, Zundelevich A, Jacob-Hirsch J, Rechavi G, Shamir R, Kloog Y.
    Cancer Res; 2007 Apr 01; 67(7):3320-8. PubMed ID: 17409441
    [Abstract] [Full Text] [Related]

  • 37. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
    Moreno-Bueno G, Fernandez-Marcos PJ, Collado M, Tendero MJ, Rodriguez-Pinilla SM, Garcia-Cao I, Hardisson D, Diaz-Meco MT, Moscat J, Serrano M, Palacios J.
    Cancer Res; 2007 Mar 01; 67(5):1927-34. PubMed ID: 17332319
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic targeting of apoptosis pathways in cancer.
    Ziegler DS, Kung AL.
    Curr Opin Oncol; 2008 Jan 01; 20(1):97-103. PubMed ID: 18043263
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.